Under construction – not a live service
Sign in

NCT07265232WithdrawnPhase 3

Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).

Source: ClinicalTrials.gov · Last updated 25 Sept 2026

Reason given: Study withdrawn prior to participant enrollment following a reassessment of the clinical development plan.

Brief summary (registry, in English)

The study objective is to determine the real-world safety and effectiveness of Vesemnogene lantuparvovec for the treatment of SMA. The specific objectives are: * To determine clinical effectiveness of Vesemnogene lantuparvovec therapy for SMA as evaluated by developmental gross motor milestone and survival. * To describe the safety profile of Vesemnogene therapy for SMA as evaluated by adverse events reporting and laboratory tests, and monitoring of Adverse events of special interest.

Status (registry)
Withdrawn
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
0 (actual)
First submitted
21 Nov 2025
Start date
15 Oct 2025
Primary completion date
15 Oct 2030
Lead sponsor
Lantu Biopharma
NCT number
NCT07265232

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Willing and able to give written informed consent for participation in the study.
  • Genetic confirmation of SMA (biallelic deletion or mutation of SMN1).
  • SMA clinical phenotype and condition, that in the opinion of the treating physician, treatment with Vesemnogene will likely be beneficial.
  • Absence of contraindications for spinal tap procedure or administration of intrathecal therapy.
  • Total AAV antibody titres < 1:20 as determined by ELISA assay.
  • Normal liver function (AST/ALT < 3XULN, Bilirubin <3.0 mg/dL).
  • Unable to access or failure to respond to currently available curative treatments for SMA.

Age in the registry: 6 months to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Tzu chi hospitalJakartaIndonesiaUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.